Sectors - Health Care  

Previously denying approval to Vivus' drug Qnexa, FDA advisory committee now declares benefits outweigh risks

The organization will continue to provide grants to Planned Parenthood to help provide women with basic screening and breast cancer education

Walgreens is starting the new 2012 year by losing millions of its customers. The well-known pharmacy will no longer provide to those customers whose health insurance is covered by Express Scripts.

Johnson & Johnson require daily dosage of Extra Strength Tylenol to drop to six pills from eight

Healthcare provider Kaiser Permanente ranks highest by J.D. Power and Associates for Employer Satisfaction

The World Health Organization says cell phones can create 'carcinogenic hazard' and cancer

Johnson & Johnson plans to buy Synthes to build its expanding orthopedic-device branch

Experian, a leading global services information company, revealed the “State of Credit,” its list of cities with the highest and lowest credit scores. According to the list, Minneapolis, Minn., Madison, Wis. and Cedar Rapids, Iowa, topped the list. At...

Gilead Sciences, a leading California-based biopharmaceutical company, announced the acquisition of CGI Pharmaceuticals for $120 million. CGI is a privately-held pharmaceutical company that specializes in small molecule chemistry and kinase biology for oncology and immunology and has a library of small molecule kinase inhibitors.

United American Healthcare Corporation will acquire Pulse Systems, Inc for $3.4 million in cash and a $1.75 million promissory note with a due date of January 2011. UAHC will issue common stock to stockholders of Pulse Systems by the end of this year and will invest money repay Pulse Systems’ bank debt.

The American Medical Association (AMA) announced three new public health policies at their annual meeting pertaining to the oil spill, nutritional labels and improving the affordability of healthy food to obesity in Americans.

Allscripts and Eclipsys have agreed to merge in an all-stock transaction that is worth about $1.3 billion. The merger will create a single healthcare information company with the largest network of clients. Eclipsys stockholders are expected to receive 1.2 shares of Allscripts for every share of Eclipsys stock based on Tuesday’s closing price.

Grifols, the global leaders in plasma protein therapies, announced the acquisition of U.S. based Talecris Biotherapeutics, a global biotherapeutic and biotechnology company $3.4 billion. The acquisition will position Grifols as a global leader in plasma protein therapeutics.

The “computer ranch” at the Southwest Foundation for Biomedical Research (SFBR) received a $2 million federal grant which will allow it to double their computing power and increase their storage capacity 20-fold this summer. The “computer ranch” is home of the world’s largest clusters of computers for human gene research.

3M is helping healthcare providers comply with new breach reporting guidelines. The Minneapolis-based company has announced a breach notification tool for use on the latest versions of 3M ChartRelease™ software and 3M DisclosureTrac™ software.

SonoSite, Inc., the Washington-based leader in point-of-care ultrasound technology announced the acquisition of Visualsonics, a privately held company that focuses on real-time ultra high-frequency micro ultrasound technology for the pre-clinical research market for $71 million in cash and debt.

Medtronic, the leading medical device and technology company, posted a revenue of $15.817 billion for the fiscal year 2010. Revenues are up 8 percent from FY 2009.

Pfizer Global Manufacturing is shaking up its facilities around the world and reconfiguring their networks. The company has decided to close facilities in eight locations and reduce the workforce in six others by 2015 in an effort to improve efficiency and production processes and lower costs.

Tokyo-based Astellas Pharma Inc announced the acquisition of leading American-based biotechnology company OSI Pharmaceuticals, Inc. The agreement is an all-cash transaction worth an estimated $4.0 billion.